drugset / Trial / NCT04471441
Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients.
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of CertiroBell® tablet compared with mycophenolate mofetil in primary living donor liver transplant recipients.
Timeline
- Start
- 2020-06-30
- Primary completion
- 2024-07-24
- Completion
- 2024-07-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | 1 mg | Oral |
| Comparator | Mycophenolate Mofetil | Small molecule | 1.5 g | Oral |
Indications
No indication recorded.